FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to chemical-pharmaceutical industry and represents pharmaceutical composition of prolonged action which includes non-agglomerated particles, containing active substance glycine and auxiliary substances, characterised by the fact that non-agglomerated particles represent nanoparticles with size from 170 to 500 nm, containing biodegradable polymer, as auxiliary substance polyvinyl alcohol as SAS, poloxamer as stabilising agent and cryoprotectant.
EFFECT: invention ensures increase of bioavailability of active substance glycine resulting from application in composition of biodegradable polymer, due to which coefficient of transmission and glycine assimilability increase, and time of glycine activity in organism grows.
4 cl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
RIFAMPICIN-BASED MEDICATION WITH PROLONGED ACTION FOR TREATMENT OF RESISTENT FORMS OF TUBERCULOSIS | 2010 |
|
RU2418585C1 |
POLYMER CONTAINING MEDICINAL AGENT BASED ON ANTITUMOR AGENT ETOPOSIDE | 2015 |
|
RU2595859C1 |
D-CYCLOSERIN-BASED MEDICATION OF PLOLONGED ACTION WITH DOSED RELEASE IN TARGET ORGANS FOR TREATMENT OF RESISTANT FORMS OF TUBERCULOSIS | 2008 |
|
RU2403041C2 |
PROLONGED-RELEASE ANTITUMOUR THERAPEUTIC AGENT BASED ON ANASTROZOLE, ANTITUMOUR PREPARATION, OESTROGEN SYNTHESIS INHIBITOR | 2013 |
|
RU2548722C1 |
ANTIBACTERIAL AGENT FOR TREATMENT OF INTRACELLULAR INFECTION | 2006 |
|
RU2308970C1 |
PROLONGED ACTION THERAPEUTIC AGENT BASED ON ANASTROZOLE | 2017 |
|
RU2659689C1 |
DRUG PREPARATION FOR PARKINSON DISEASE | 2014 |
|
RU2545734C1 |
DRUG OF ANTI-TUBERCULOSIS ACTION ON THE BASIS OF D-CYCLOSERINE IN THE FORM OF A LYOPHILISATE AND METHOD OF PRODUCING A MEDICINAL PREPARATION | 2015 |
|
RU2606839C1 |
ANTICANCER DRUG BASED ON NICLOSAMIDE | 2016 |
|
RU2617049C1 |
AGENT FOR BACTERIAL INFECTIONS TREATMENT | 2007 |
|
RU2337711C1 |
Authors
Dates
2012-08-10—Published
2011-03-25—Filed